Home
Live Updates
Epilepsia Publishes Interim Results of Open-Label Extension Study of FINTEPLA® (fenfluramine) Oral Solution in Patients with Lennox-Gastaut Syndrome (LGS) : comparemela.com
Epilepsia Publishes Interim Results of Open-Label Extension Study of FINTEPLA® (fenfluramine) Oral Solution in Patients with Lennox-Gastaut Syndrome (LGS)
Peer-reviewed results from the Phase 3 open-label extension study of FINTEPLA® in LGS provide significant reduction in the frequency of multiple seizure types...
Related Keywords
Colorado ,
United States ,
Japan ,
Brussels ,
Bruxelles Capitale ,
Belgium ,
France ,
Smyrna ,
Izmir ,
Turkey ,
French ,
Erica Puntel ,
Kelly Knupp ,
Antje Witte ,
Group Of Companies ,
Twitter ,
Ucb Inc ,
Zogenix Inc ,
Program See Boxed Warning ,
Euronext ,
Associate Professor ,
Hospital Colorado ,
Mitigation Strategy ,
Prescribing Information ,
Boxed Warning ,
Heart Disease ,
Pulmonary Arterial Hypertension ,
Decreased Weight ,
Antiepileptic Drugs ,
Blood Pressure ,
Euronext Brussels ,
Lennox Gastaut Syndrome ,
Ucb ,
comparemela.com © 2020. All Rights Reserved.